Authors

  • Сахибоев Д.П., Болтаев А.А., Парпижалилова Ч.Д.

References

1. Aboyans V, Ricco JB, Bartelink ML, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases. Eur Heart J. 2017.

2. Cai J, et al. Polyvascular Atherosclerosis in the General Population: The PRECISE Study. JAMA Netw Open. 2022.

3. Collet JP, et al. 2020 ESC Guidelines for ACS management. Eur Heart J. 2020.

4. Criqui MH, et al. The prevalence and prognostic value of polyvascular disease: MESA. JACC. 2019.

5. Gabriyelyan A.V., Cheveliuk O.V. Features of Myocardial Revascularization in Multifocal Atherosclerosis with Involvement of Coronary Arteries and Lower Limb Arteries. Ukrainian Journal of Cardiovascular Surgery. 2024;32(4):14-19.

6. Gao J., Cheng Y. Ultrasound-based prevalence of polyvascular disease and its association with adverse outcome in patients undergoing coronary artery bypass grafting. Science Progress. 2024;107 (4).

7. Gkolfinopoulou C, et al. Polyvascular disease and MACE risk. Atherosclerosis. 2021.

8. Hiatt W.R., et al. Rivaroxaban in Peripheral Artery Disease — after Revascularization. New England Journal of Medicine (NEJM). 2020;382:1994–2004.

9. Наврузов, Б., Тешаев, О., Холов, Х., Убайдуллаев, З., & Ортикбоев, Ф. (2023). Недоста-точность сфинктера при операции на экстра-сфинк терных свищей (обзор литературы). Евра-зийский журнал медицинских и естественных наук, 3(4), 55-67.

10. Libby P. Inflammation in Atherosclerosis: From Theory to Practice. Cell. 2021.

11. Lipid Cardio Study Investigators. Polyvascular atherosclerosis and renal dysfunction increase the odds of cognitive impairment in vascular disease: findings of the LipidCardio study. European Journal of Medical Research. 2024;29:141.

12. Musiałek P., Montauk L., Saugnet A., Micari A., Hopkins L.N. The prevalence of polyvascular disease in patients with carotid artery disease and peripheral artery disease. Kardiologia Polska (Kardiol Pol). 2019;77(10):899–901.

13. Parton A., McGilligan V., OKane M., Baldrick F.R., Watterson S. Computational Modelling of Atherosclerosis. 2015.

14. Polonetsky O.L., Polonetsky L.Z. Endothelial Dysfunction and Atherosclerosis // Medical News. 2012. No. 6

15. Safian R.D., Textor S.C. Renal-Artery Stenosis. New England Journal of Medicine (NEJM). 2001;344:431–442.

16. Ergashev, U. Y., Abdusalomov, B. A., Minavarkhojayev, R. R., Ortiqboyev, F. D., & Malikov, N. M. (2023). Evaluation of the pathomorphology of regeneration in diabetic foot syndrome and determination of its dependence on biochemical processes. World Bulletin of Public Health, 19, 66-78.

17. Shah PK. Plaque Vulnerability and Inflammation. J Am Coll Cardiol. 2020.

18. Van Kuijk J-P, et al. Polyvascular Disease: Clinical Outcomes and Predictors. Eur J Vasc Surg. 2020.

19. Virani SS, Smith S, et al. Heart Disease and Stroke Statistics — 2023. Circulation. 2023.

20. Weissler E.H., et al. Polyvascular Disease: a narrative review of risk factors, clinical outcomes and treatment. Atherosclerosis. 2020;315:102–113.

21. Xu S, et al. Vasa Vasorum, Inflammation, and Plaque Progression. Arterioscler Thromb Vasc Biol. 2015.

22. Yazdani S, et al. Intravascular Imaging of Vulnerable Plaques. Nat Rev Cardiol. 2021.

23. Zhu C-Y., Zhang J-N., Tse Y-K., Ren Q-W., Huang J-Y., Yu S-Y., Gu R., Gu W-L., Chan D.T-L., Lip G.Y.H., Yiu K-H. Prevalence, Clinical Characteristics and Prognosis of Vascular Disease in Valvular Heart Surgery: A Multi-Centre Study. Global Heart. 2025;20(1):71.

24. Ortiqboyev, F. (2023). To'qima muhandislik konstruktsiyalari, teri ekvivalentlari va ularni trofik yara kasaligini davolashda foydalanish. Евразийский журнал медицинских и естествен-ных наук, 3(8), 43-52.